Eris Lifesciences Limited
NSE:ERIS.NS
1647.4 (INR) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,026 | 7,221.2 | 7,411.7 | 7,197.2 | 5,509.25 | 4,834.81 | 5,005.2 | 4,600.29 | 3,965.92 | 4,178.4 | 4,553.32 | 3,920.52 | 3,011.01 | 3,280.74 | 3,533.37 | 3,436.56 | 2,742.53 | 3,050.42 | 3,252.67 | 2,880.12 | 2,440.85 | 2,617.53 | 2,804.56 | 2,718.89 | 2,110.85 | 2,484.78 | 2,605.62 | 2,507.61 | 2,121.92 | 2,089.71 | 2,492.34 | 1,852.07 | 1,591.48 | 1,844.7 | 1,989.16 | 1,824.23 |
| Cost of Revenue
| 1,702.5 | 1,768.8 | 3,923.8 | 3,891.5 | 2,745.59 | 888.69 | 945.97 | 783.95 | 727.57 | 887.82 | 1,057.2 | 850.91 | 640.9 | 614.4 | 664 | 688.66 | 640.27 | 564.29 | 638.29 | 575.85 | 443.04 | 428.18 | 457.21 | 458.93 | 363.21 | 393.92 | 405.65 | 388.66 | 351.19 | 336.69 | 399.76 | 274.58 | 304.47 | 221.04 | 233.26 | 309.26 |
| Gross Profit
| 5,323.5 | 5,452.4 | 3,487.9 | 3,305.7 | 2,763.66 | 3,946.12 | 4,059.23 | 3,816.34 | 3,238.35 | 3,290.58 | 3,496.12 | 3,069.61 | 2,370.11 | 2,666.34 | 2,869.37 | 2,747.9 | 2,102.26 | 2,486.13 | 2,614.38 | 2,304.27 | 1,997.81 | 2,189.35 | 2,347.35 | 2,259.96 | 1,747.64 | 2,090.86 | 2,199.97 | 2,118.95 | 1,770.73 | 1,753.02 | 2,092.58 | 1,577.49 | 1,287.01 | 1,623.66 | 1,755.9 | 1,514.97 |
| Gross Profit Ratio
| 0.758 | 0.755 | 0.471 | 0.459 | 0.502 | 0.816 | 0.811 | 0.83 | 0.817 | 0.788 | 0.768 | 0.783 | 0.787 | 0.813 | 0.812 | 0.8 | 0.767 | 0.815 | 0.804 | 0.8 | 0.818 | 0.836 | 0.837 | 0.831 | 0.828 | 0.841 | 0.844 | 0.845 | 0.834 | 0.839 | 0.84 | 0.852 | 0.809 | 0.88 | 0.883 | 0.83 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61 | 0 | 0 | 0 | 327.38 | 0 | 0 | 0 | 50.92 | 0 | 0 | 0 | 41.96 | 0 | 0 | 0 | 41.12 | 0 | 0 | 0 | 7.74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,189.54 | 0 | 0 | 0 | 633.63 | 0 | 0 | 0 | 582.44 | 0 | 0 | 0 | 633.57 | 0 | 0 | 0 | 651.67 | 0 | 0 | 0 | 496.67 | 0 | 0 | 0 | 380.77 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63.85 | 0 | 0 | 0 | 87.47 | 0 | 0 | 0 | 125.05 | 0 | 0 | 0 | 182.38 | 0 | 0 | 0 | 367.01 | 0 | 0 | 0 | 373.37 | 0 | 0 | 0 | 378.27 | 0 | 0 | 0 |
| SG&A
| 1,214.5 | 0 | 1,647.6 | 1,565.2 | 1,818.35 | 1,232.44 | 1,310.27 | 1,041.34 | 1,253.39 | 1,102.73 | 1,081.74 | 786.09 | 721.1 | 615.91 | 629.56 | 883.72 | 707.49 | 596.92 | 599.99 | 570.97 | 815.95 | 524.29 | 505.11 | 471.49 | 1,018.68 | 474.52 | 468.95 | 490.81 | 870.04 | 428.19 | 372.71 | 356.5 | 759.04 | 314.55 | 348.96 | 314.05 |
| Other Expenses
| 0 | 3,761.3 | 0 | 16.4 | 151.48 | 41.97 | 34.81 | 9.89 | 10.04 | 22.37 | 51.74 | 27.38 | -169.94 | 51.78 | 69.87 | 58.65 | -60.4 | 30.72 | 20.84 | 13.39 | -128 | 84.66 | 51.7 | 28.26 | -182.25 | 102.88 | 61.53 | 35.24 | -183.61 | 57.84 | 64.52 | 68.67 | -197.77 | 55.38 | 91.71 | 51.54 |
| Operating Expenses
| 1,214.5 | 3,761.3 | 1,647.6 | 1,565.2 | 1,818.35 | 2,648.19 | 2,668.73 | 2,527.83 | 2,400.71 | 2,217.54 | 2,267.84 | 2,011.99 | 1,536.55 | 1,617.92 | 1,620.74 | 1,627.79 | 1,259.85 | 1,519.88 | 1,472.34 | 1,367.95 | 1,314.91 | 1,548.52 | 1,366.21 | 1,329.93 | 1,214.27 | 1,251.54 | 1,275.9 | 1,306.19 | 1,142.98 | 1,008.97 | 1,167.69 | 909.36 | 869.05 | 959.74 | 1,064.05 | 833.15 |
| Operating Income
| 4,109 | 1,691.1 | 1,840.3 | 1,740.5 | 945.31 | 1,339.9 | 1,425.31 | 1,288.51 | 847.68 | 1,095.41 | 1,280.02 | 1,057.62 | 827.88 | 1,048.42 | 1,248.63 | 1,120.11 | 842.41 | 966.25 | 1,142.04 | 936.32 | 682.9 | 640.83 | 981.14 | 930.03 | 533.37 | 839.32 | 924.07 | 812.76 | 626.64 | 744.05 | 924.89 | 668.13 | 417.96 | 663.92 | 691.85 | 681.82 |
| Operating Income Ratio
| 0.585 | 0.234 | 0.248 | 0.242 | 0.172 | 0.277 | 0.285 | 0.28 | 0.214 | 0.262 | 0.281 | 0.27 | 0.275 | 0.32 | 0.353 | 0.326 | 0.307 | 0.317 | 0.351 | 0.325 | 0.28 | 0.245 | 0.35 | 0.342 | 0.253 | 0.338 | 0.355 | 0.324 | 0.295 | 0.356 | 0.371 | 0.361 | 0.263 | 0.36 | 0.348 | 0.374 |
| Total Other Income Expenses Net
| -2,820.3 | -529.5 | -549.2 | -587.3 | -178.84 | -139.21 | -128.14 | -163.67 | -78.63 | -7.65 | -18.96 | -44.91 | 19.82 | 41.37 | 59.21 | 50.86 | 4.87 | 26.71 | 16.32 | 9.34 | -67.94 | 80.77 | 46.56 | 19.21 | -80.72 | 51.8 | -0.96 | -35.81 | -4.5 | 30.21 | -730.63 | -484.34 | -8.02 | 55.13 | -631.24 | -467.89 |
| Income Before Tax
| 1,288.7 | 1,161.6 | 1,291.1 | 1,153.2 | 766.47 | 1,158.72 | 1,262.36 | 1,124.84 | 759.01 | 1,065.39 | 1,209.32 | 1,012.71 | 853.38 | 1,089.79 | 1,307.84 | 1,170.97 | 847.28 | 992.96 | 1,158.36 | 946.37 | 614.96 | 721.6 | 1,027.7 | 949.24 | 582.4 | 891.12 | 923.11 | 776.95 | 622.14 | 774.26 | 989.24 | 736.65 | 409.94 | 719.05 | 775.7 | 733.03 |
| Income Before Tax Ratio
| 0.183 | 0.161 | 0.174 | 0.16 | 0.139 | 0.24 | 0.252 | 0.245 | 0.191 | 0.255 | 0.266 | 0.258 | 0.283 | 0.332 | 0.37 | 0.341 | 0.309 | 0.326 | 0.356 | 0.329 | 0.252 | 0.276 | 0.366 | 0.349 | 0.276 | 0.359 | 0.354 | 0.31 | 0.293 | 0.371 | 0.397 | 0.398 | 0.258 | 0.39 | 0.39 | 0.402 |
| Income Tax Expense
| 265.2 | 292.3 | 327.6 | 259 | -29.86 | 144.12 | 39.24 | 188.35 | 144.23 | 63.08 | 15.56 | 81.96 | 53.66 | 82.14 | 123.91 | 104.38 | 164.81 | 91.46 | 81.16 | 56.19 | 52.24 | 86.91 | 100.59 | 108.69 | 43.56 | 89.14 | 68.05 | 61.36 | 61.36 | 25.05 | 57.82 | 28.28 | -8.24 | 38.29 | 83.22 | 105.46 |
| Net Income
| 938.4 | 836.3 | 915.9 | 831.8 | 709.62 | 1,027.36 | 1,234.3 | 948.6 | 654.18 | 1,018.59 | 1,203.04 | 945.77 | 802.96 | 1,007.65 | 1,183.93 | 1,066.59 | 682.47 | 901.5 | 1,077.2 | 890.18 | 562.72 | 634.69 | 927.11 | 840.45 | 540.87 | 801.38 | 853.2 | 712.51 | 557.87 | 746.13 | 928.68 | 708.37 | 425.13 | 681.04 | 690.22 | 624.39 |
| Net Income Ratio
| 0.134 | 0.116 | 0.124 | 0.116 | 0.129 | 0.212 | 0.247 | 0.206 | 0.165 | 0.244 | 0.264 | 0.241 | 0.267 | 0.307 | 0.335 | 0.31 | 0.249 | 0.296 | 0.331 | 0.309 | 0.231 | 0.242 | 0.331 | 0.309 | 0.256 | 0.323 | 0.327 | 0.284 | 0.263 | 0.357 | 0.373 | 0.382 | 0.267 | 0.369 | 0.347 | 0.342 |
| EPS
| 6.9 | 6.15 | 6.73 | 6.11 | 5.22 | 7.55 | 9.07 | 6.98 | 4.81 | 7.49 | 8.85 | 6.96 | 5.91 | 7.41 | 8.71 | 7.86 | 5.03 | 6.65 | 7.93 | 6.56 | 4.14 | 4.62 | 6.74 | 6.11 | 3.98 | 5.83 | 6.2 | 5.18 | 4.06 | 5.43 | 6.71 | 5.15 | 3.13 | 4.95 | 5.02 | 4.56 |
| EPS Diluted
| 6.89 | 6.14 | 6.72 | 6.1 | 5.21 | 7.54 | 9.06 | 6.98 | 4.79 | 7.49 | 8.84 | 6.95 | 5.91 | 7.41 | 8.71 | 7.85 | 5.03 | 6.63 | 7.93 | 6.55 | 4.14 | 4.61 | 6.73 | 6.11 | 3.98 | 5.83 | 6.2 | 5.17 | 4.06 | 5.43 | 6.71 | 5.15 | 3.13 | 4.95 | 5.02 | 4.56 |
| EBITDA
| 2,540.05 | 2,545.3 | 2,690.6 | 2,516.3 | 1,635.8 | 1,797.06 | 1,846.25 | 1,707.34 | 1,198.98 | 1,394.38 | 1,566.2 | 1,319.43 | 1,049.59 | 1,269 | 1,468.09 | 1,323.81 | 967.3 | 1,103.01 | 1,268.49 | 1,054.04 | 761.68 | 852.47 | 1,150.15 | 1,073.4 | 738.8 | 1,038.12 | 1,068.4 | 920.75 | 790.33 | 868.74 | 1,042.1 | 783.04 | 478.71 | 780.87 | 830.49 | 787.46 |
| EBITDA Ratio
| 0.362 | 0.352 | 0.363 | 0.35 | 0.297 | 0.372 | 0.369 | 0.371 | 0.302 | 0.334 | 0.344 | 0.337 | 0.349 | 0.387 | 0.415 | 0.385 | 0.353 | 0.362 | 0.39 | 0.366 | 0.312 | 0.326 | 0.41 | 0.395 | 0.35 | 0.418 | 0.41 | 0.367 | 0.372 | 0.416 | 0.418 | 0.423 | 0.301 | 0.423 | 0.418 | 0.432 |